Errors in Author Contributions, Methods, and Figures 1 and 2

In the Original Investigation titled “Induction Chemotherapy Followed by Radiotherapy vs Chemoradiotherapy in Nasopharyngeal Carcinoma: a Randomized Clinical Trial,” published online February 8, 2024, there were errors in the Author Contributions and Figure. In the Key Points, “health controls” now correctly reads “healthy controls.” In the Author Contributions, Dr Cai was omitted as having contributed equally to the article, which has been corrected. In Figure 1, the number of participants who completed a full dose of radiotherapy of those who were randomized to receive induction chemotherapy plus radiotherapy was listed as 193, but should be 192. In the Methods section, cisplatin and docetaxel should be intravenously delivered on days 1 and 22 and days 43. In Figure 2, "Overall survival" should be abbreviated to "OS." DMFS should be the abbreviation of "distant metastasis-free survival." LRFFS should be the abbreviation of "locoregional failure-free survival." This article was corrected online.